期刊文献+

rhEPO对大鼠肝脏缺血再灌注损伤的保护作用

Protection of rhEPO on hepatic ischemic/reperfusion injury in rats
下载PDF
导出
摘要 目的:探讨rhEPO对大鼠肝脏缺血再灌注损伤中的保护作用及其处理时间。方法:健康Wistar大鼠36只,随机分为对照组A、缺血前30 min预处理组B和缺血后5 min后处理组C 3组,每组12只。A组只给予夹闭肝蒂,B、C组均于皮下注射rhEPO 1 000 U/kg,三组均夹闭肝蒂45 min后恢复再灌注2 h,取血清及肝组织行AST、ALT、TNF-α、IL-1β检测及HE染色、NF-κβ的活化程度及计算肝组织凋亡指数(AI)。结果:与A组比较,B、C组肝细胞索排列较好,细胞坏死程度不明显。AST、ALT和TNF-α、IL-1β及NF-κB活化程度、AI在A组和B、C组之间均有显著差异(P<0.05),B和C组之间(除IL-1β外)也具有统计学意义(P<0.05)。结论:rhEPO对缺血再灌注损伤的肝脏具有保护作用且预处理较后处理效果好。 Objectives:To explore the protective effect of rhEPO on hepatic ischemia reperfusion injury in rats and treatment time. Methods:Thirty-six wistar rats were randomly divided into three groups, the control group A, the rhEPO pretreatment group B and postprocessing group C,n= 12 respectively. Liver pedicles were occlused in group, rats were injected rhEPO 1 000 U/kg into subcutaneously 30 minutes before ischemia in B group or 5 minutes after in C group A. After 45 minutes ischemia,then followed reperfusion. Serum aspartic acid aminotransferase(AST)and alanine aminotransferase(ALT),tumor necrosis factor α(TNF-α) and interleukin 1 β(IL-1β)were measured and liver histo-pathology was observed by HE staining. Nuclear factor κB(NF-κB) was detected by immunohistochemistry and apoptotic index was calculated by TUNEL. Results:Compared to group A,the arrargement of liver cell--line is relatively better and the cells were damaged insignificantly in group B and C. The serum concentration of AST,ALT, TNF-α,IL-1β,NF-κB and AI in group A have difference significantly(P〈0. 05),and group B and C had statistical significance (except IL-1β). Conclusion:RhEPO protects the liver from ischemia reperfusion injury in rats and pretreatment is better than postprocessing.
出处 《临床医药实践》 2008年第4期253-256,共4页 Proceeding of Clinical Medicine
关键词 人类重组促红细胞生成素 缺血再灌注损伤 预处理 后处理 肝脏 recombinant human erythropoietin (rhEPO) ischemia reperfusion injury (IRI), pretreatment postprocessing liver
  • 相关文献

参考文献14

  • 1Krantz S B. Erythropoietin [J]. Blood, 1991,77: 419- 434.
  • 2Constantinescu S N ,Ghaffari S,Lodish H F. The erythropoietin receptor: structure, activation and intracellular signal transduction [J]. Trends Endocrinol Metib, 1999,10: 18-23.
  • 3Engert A. Recombinant human erythropoietin in oncology:current status and further developments[J]. Annals of Oncology,2005:16:1 584-1 595.
  • 4Ludmila B,Larissa K,Weizhan Zhao,et al. Neuroprotective effect of darbepoetin alfa,a novel recombinant erythropoietic protein,in focal cerebral ischemia in rats[J].Stroke,2005,36:1 071-1 076.
  • 5Yoshiya A,Takao S,Ichiro Y ,et al. Preventive effect of erythropoietin on spinal cord cell apoptosis following acute traumatic injury in rats[J]. Spine,2006,31 : 2 432-2 438.
  • 6Junk A K,Mammis A,Savrrz S L,et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury [J]. Proc Natl Acad Sci USA,2002,99:10 659-10 664.
  • 7Erik L, Peter vander M, Robert H,et al. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion [J]. J Cardiovasc Pharmacol, 2004,44:473-479
  • 8Zheqing Cai,Dominador J M,Guo Wei,et al. Hearts from rodents exposed to inter-mittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury [J]. Circulation, 2003,108 : 79-85.
  • 9Evangelia S, Ioannis T, George K, et al. Erythropoietin attenuatesrenal injury in experimental acute renal failure ischemic/reperfusion model [J]. Nephrol Dial Transplant, 2006,21 : 330-336.
  • 10Vvesey D A,Cheung C,Pat B,et al. Erythropoietin protects against ischemic acute renal injury[J]. Archives,1997,157(6):1 833-1 838.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部